On March 2, 2016, Robin Stracey, the Chief Executive Officer of Cesca Therapeutics Inc. was appointed by the company's Board of Directors to the additional office of President of the company effective as of March 2, 2016. In connection with Mr. Stracey's appointment, Mr. Stracey will continue to serve as a member of the company's Board of Directors, will maintain his position as Chief Executive Officer and will maintain his current salary and compensation arrangements.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.619 USD | -4.61% | +5.47% | +3.00% |
1st Jan change | Capi. | |
---|---|---|
+3.00% | 4.92M | |
+8.02% | 7.92B | |
-4.60% | 4.59B | |
-4.69% | 2.98B | |
+9.00% | 2.18B | |
+11.86% | 1.05B | |
-32.46% | 1.03B | |
+2.71% | 905M | |
-27.13% | 716M | |
-54.84% | 714M |
- Stock Market
- Equities
- THMO Stock
- News ThermoGenesis Holdings, Inc.
- Cesca Therapeutics Inc. Appoints Robin Stracey as President